Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism - PubMed

Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism

I Edery et al. Cell. 1989.

Abstract

All mRNAs of human immunodeficiency virus 1 (HIV-1) contain in their 5' untranslated region a sequence termed TAR that responds to trans-activation by the tat (trans-activating) protein. This RNA sequence assumes a stable secondary structure, and its cap structure is relatively inaccessible. Here we report that these structural properties of the TAR sequence underlie the ability of TAR to inhibit in trans the translation of other mRNAs. This mechanism of translation inhibition involves the activation of the double-stranded RNA-dependent kinase (dsl), which in turn phosphorylates the protein synthesis initiation factor 2 (eIF-2). Mutations in the TAR region that diminish the stability of the secondary structure cause a significant reduction in the trans-inhibition. A similar reduction in the dsl activation occurs when TAR is placed further downstream of the cap structure. This is a clear demonstration of a specific naturally occurring mRNA sequence that can activate dsl. We suggest a novel translational regulatory mechanism that interdigitates the activities of eIF-2 and eIF-4F.

Similar articles

• Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function.

  Gunnery S, Green SR, Mathews MB. Gunnery S, et al. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11557-61. doi: 10.1073/pnas.89.23.11557. Proc Natl Acad Sci U S A. 1992. PMID: 1360669 Free PMC article.

• La autoantigen alleviates translational repression by the 5' leader sequence of the human immunodeficiency virus type 1 mRNA.

  Svitkin YV, Pause A, Sonenberg N. Svitkin YV, et al. J Virol. 1994 Nov;68(11):7001-7. doi: 10.1128/JVI.68.11.7001-7007.1994. J Virol. 1994. PMID: 7933082 Free PMC article.

• Modification of eukaryotic initiation factor 4F during infection by influenza virus.

  Feigenblum D, Schneider RJ. Feigenblum D, et al. J Virol. 1993 Jun;67(6):3027-35. doi: 10.1128/JVI.67.6.3027-3035.1993. J Virol. 1993. PMID: 8098776 Free PMC article.

• RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.

  Naryshkin NA, Gait MJ, Ivanovskaya MG. Naryshkin NA, et al. Biochemistry (Mosc). 1998 May;63(5):489-503. Biochemistry (Mosc). 1998. PMID: 9632883 Review.

• Tackling Tat.

  Karn J. Karn J. J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060. J Mol Biol. 1999. PMID: 10550206 Review.

Cited by

• Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs.

  Kozak M. Kozak M. Mol Cell Biol. 1989 Nov;9(11):5134-42. doi: 10.1128/mcb.9.11.5134-5142.1989. Mol Cell Biol. 1989. PMID: 2601712 Free PMC article.

• Analysis of PKR activation using analytical ultracentrifugation.

  Cole JL. Cole JL. Macromol Biosci. 2010 Jul 7;10(7):703-13. doi: 10.1002/mabi.201000069. Macromol Biosci. 2010. PMID: 20533534 Free PMC article.

• Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR.

  Benkirane M, Neuveut C, Chun RF, Smith SM, Samuel CE, Gatignol A, Jeang KT. Benkirane M, et al. EMBO J. 1997 Feb 3;16(3):611-24. doi: 10.1093/emboj/16.3.611. EMBO J. 1997. PMID: 9034343 Free PMC article.

• Variable inhibition of cell-free translation by HIV-1 transcript leader sequences.

  Geballe AP, Gray MK. Geballe AP, et al. Nucleic Acids Res. 1992 Aug 25;20(16):4291-7. doi: 10.1093/nar/20.16.4291. Nucleic Acids Res. 1992. PMID: 1354856 Free PMC article.

• A highly efficient human cell-free translation system.

  Aleksashin NA, Chang ST, Cate JHD. Aleksashin NA, et al. RNA. 2023 Dec;29(12):1960-1972. doi: 10.1261/rna.079825.123. Epub 2023 Oct 4. RNA. 2023. PMID: 37793791 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal